Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 21 Show results per page	View Search Criteria \| Help With Results

Last Modified: 3/1/1991


1.		Phase II Study of Piroxantrone in Patients with Advanced Renal Cell Carcinoma (Summary Last Modified 03/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				ICC-89U3 NCI-T89-0166D, T89-0166

Last Modified: 11/1/1990


2.		Phase II Study of Piroxantrone in Patients with Stage IV non-Small Cell Lung Cancer (Summary Last Modified 11/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				SWOG-8866 SWOG-8866

Last Modified: 2/1/1991


3.		Phase II Evaluation of Piroxantrone in Patients with Advanced Renal Cell Carcinoma (Summary Last Modified 02/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				SWOG-8945 SWOG-8945

Last Modified: 9/13/2006


4.		Phase II Randomized Study of Merbarone vs Piroxantrone in Patients with Metastatic non-Small Cell Bronchogenic Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				any age				NCI				EST-1589 EST-1589

Last Modified: 8/1/1990


5.		Phase II Trial of Piroxantrone for Advanced Soft-Tissue Sarcomas (Summary Last Modified 08/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				SWOG-8930 SWOG-8930

Last Modified: 8/1/1990


6.		Phase II Study of Piroxantrone in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 08/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				SWOG-8932 SWOG-8932

Last Modified: 1/1/1991


7.		Phase II Evaluation of Piroxantrone in Patients with Pancreatic Adenocarcinoma (Summary Last Modified 01/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				SWOG-8933 SWOG-8933

Last Modified: 1/1/1991


8.		Phase II Evaluation of Piroxantrone in Patients with Gastric Carcinoma (Summary Last Modified 01/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				SWOG-8936 SWOG-8936

Last Modified: 1/1/1992


9.		Phase II Study of Piroxantrone in Patients with Refractory Carcinoma of the Breast (Summary Last Modified 01/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				SWOG-8911 SWOG-8911

Last Modified: 10/1/1991


10.		Phase II Randomized Study of Merbarone vs Piroxantrone in Patients with Recurrent Ovarian Cancer (Summary Last Modified 10/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				SWOG-8904 SWOG-8904

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute